Hermans Stefan J, Ascher David B, Hancock Nancy C, Holien Jessica K, Michell Belinda J, Chai Siew Yeen, Morton Craig J, Parker Michael W
ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Fitzroy, Melbourne, Victoria, 3065, Australia.
Protein Sci. 2015 Feb;24(2):190-9. doi: 10.1002/pro.2604. Epub 2014 Dec 26.
Insulin-regulated aminopeptidase (IRAP or oxytocinase) is a membrane-bound zinc-metallopeptidase that cleaves neuroactive peptides in the brain and produces memory enhancing effects when inhibited. We have determined the crystal structure of human IRAP revealing a closed, four domain arrangement with a large, mostly buried cavity abutting the active site. The structure reveals that the GAMEN exopeptidase loop adopts a very different conformation from other aminopeptidases, thus explaining IRAP's unique specificity for cyclic peptides such as oxytocin and vasopressin. Computational docking of a series of IRAP-specific cognitive enhancers into the crystal structure provides a molecular basis for their structure-activity relationships and demonstrates that the structure will be a powerful tool in the development of new classes of cognitive enhancers for treating a variety of memory disorders such as Alzheimer's disease.
胰岛素调节氨肽酶(IRAP或催产素酶)是一种膜结合锌金属肽酶,可裂解大脑中的神经活性肽,并在受到抑制时产生增强记忆的作用。我们已经确定了人IRAP的晶体结构,其呈现出一种封闭的四结构域排列,有一个大的、大部分被掩埋的腔邻接活性位点。该结构表明,GAMEN外肽酶环采用了与其他氨肽酶非常不同的构象,从而解释了IRAP对诸如催产素和加压素等环肽的独特特异性。将一系列IRAP特异性认知增强剂对接至晶体结构中进行计算,为它们的构效关系提供了分子基础,并证明该结构将成为开发用于治疗多种记忆障碍(如阿尔茨海默病)的新型认知增强剂的有力工具。